SCHEMBL910274

SCHEMBL910274

COc1nc(F)cc2nc(S(=O)(=O)Nc3c(F)cccc3F)nn12

nearest known ligand 0.58

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TSHR P16473 1/20 0.40
SLC40A1 Q9NP59 1/20 0.38
CCR4 P51679 1/20 0.34
ACLY P53396 1/20 0.33
ALOX5AP P20292 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8902858 0.90 SMN1; SMN2 (0.35) GAAMAPK1KMT2ASMN1; SMN2TSHR
SCHEMBL8113170 0.90 TSHR (0.39) TSHRCCR4
SCHEMBL6999983 0.88 TSHR (0.36) GAAMAPK1KMT2ASMN1; SMN2TSHR
SCHEMBL7074184 0.86 TSHR (0.34) GAAMAPK1KMT2ASMN1; SMN2TSHR
SCHEMBL8612969 0.85 SLC40A1 (0.43) KMT2ASLC40A1
SCHEMBL8848572 0.83 GNRHR (0.34) TSHRCCR4ACLY
SCHEMBL8113251 0.82 LMNA (0.37) GAAKMT2ASMN1; SMN2TSHR
Diclosulam SCHEMBL407709 0.82 CCR4 (0.33) CCR4
SCHEMBL8352235 0.81 TSHR (0.42) GAAMAPK1KMT2ASMN1; SMN2TSHR
SCHEMBL8881879 0.81 TSHR (0.34) TSHRCCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2598540-B2 1997-04-09 JP claimed
WO-1989011782-A1 ALKOXY-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE-2-SULFONAMIDES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THE DOW CHEMICAL COMPANY (US) 1989-12-14 WO claimed
EP-0343752-A1 Alkoxy-1,2,4-triazolo (1,5-c) pyrimidine-2-sulfonamides, process for their preparation and intermediates DowElanco (US) 1989-11-29 EP claimed
EP-1893016-B1 WATER-IN-OIL SUSPOEMULSIONS BAYER IP GMBH (DE) 2017-09-13 EP disclosed
EP-1651039-B1 OIL SUSPENSION CONCENTRATE CONTAINING DIFLUFENICAN BAYER IP GMBH (DE) 2017-01-04 EP disclosed
US-8318637-B2 Herbicide/azole combination BAYER CROPSCIENCE AG (DE) 2012-11-27 US disclosed
US-8158557-B2 Storage-stable formulations of sulfonamides BAYER CROPSCIENCE AG (DE) 2012-04-17 US disclosed
WO-2011076731-A1 LIQUID FORMULATION OF 2-IODO-N-[(4-METHOXY-6-METHYL-1,3,5-TRIAZIN-2-YL)CARBAMOYL]BENZOLSULFONAMIDE BAYER CROPSCIENCE AG (DE) 2011-06-30 WO disclosed
US-20110152082-A1 LIQUID FORMULATIONS BAYER CROPSCIENCE AG (DE) 2011-06-23 US disclosed
US-7867946-B2 Liquid formulation BAYER CROPSCIENCE AG (DE) 2011-01-11 US disclosed
US-20100255995-A1 HERBICIDE/AZOLE COMBINATION BAYER CROPSCIENCE AG (DE) 2010-10-07 US disclosed
EP-0697016-A1 SUBSTITUTED QUINOLINE COMPOUNDS AND THEIR USE AS SAFENERS Hoechst Schering AgrEvo GmbH (DE) 1996-02-21 EP disclosed
EP-0663397-A2 Bicyclic heteroaryl compounds, process for their preparation and their use as safener Hoechst Schering AgrEvo GmbH (DE) 1995-07-19 EP disclosed
WO-1995007897-A1 SUBSTITUTED ISOXAZOLINES, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE AS SAFENERS HOECHST SCHERING AGREVO GMBH (DE) 1995-03-23 WO disclosed
WO-1994026716-A1 SUBSTITUTED QUINOLINE COMPOUNDS AND THEIR USE AS SAFENERS HOECHST SCHERING AGREVO GMBH (DE) 1994-11-24 WO disclosed
EP-0582198-A2 Substituted (hetero-)aryle compounds, process for their preparation, those containing compositions and their use as safeners Hoechst Schering AgrEvo GmbH (DE) 1994-02-09 EP disclosed
EP-0565593-A1 REDUCING PESTICIDAL INTERACTIONS IN CROPS MONSANTO COMPANY (US) 1993-10-20 EP disclosed
EP-0562015-A1 SAFENED HERBICIDAL SULFONAMIDE COMPOSITIONS MONSANTO COMPANY (US) 1993-09-29 EP disclosed
WO-1992011761-A1 REDUCING PESTICIDAL INTERACTIONS IN CROPS MONSANTO COMPANY (US) 1992-07-23 WO disclosed
WO-1992010098-A1 SAFENED HERBICIDAL SULFONAMIDE COMPOSITIONS MONSANTO COMPANY (US) 1992-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100255995-A1 HERBICIDE/AZOLE COMBINATION HTT, SOD1, ABAT GAA 184/4885MAPK1 3393/4885KMT2A 1412/4885
US-20110152082-A1 LIQUID FORMULATIONS CBX3, CBX6, IPO11 GAA 4780/4885MAPK1 2308/4885KMT2A 770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.